Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study., PMID:40508203
Advances in the treatment of ANCA-associated vasculitis., PMID:40473820
Recombinant C5a Peptidase and Formalin-Killed Cell: A Synergistic Vaccine Against Streptococcus iniae in Four-Finger Threadfin Fish (Eleutheronema tetradactylum)., PMID:40420522
The molecular adjuvant effect of the C-terminal peptide of complement C5a in a teleost fish., PMID:40373887
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis., PMID:40370446
Correlations of the Complement Proteins MASP-2 and MASP-3 With Clinical Severity and Short-Term Outcomes in Primary Membranous Nephropathy Patients., PMID:40294883
A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection., PMID:40255397
Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients., PMID:40250846
Complement C3 Deficiency Enhances Renal Leptospiral Load and Inflammation While Impairing T Cell Differentiation During Chronic Leptospira interrogans Infection., PMID:40236016
An antibody-dependent cellular phagocytosis-related gene signature predicts survival and response to immunotherapy in stomach adenocarcinoma., PMID:40193680
Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials., PMID:40192160
Emerging targeted therapies in ANCA-associated vasculitis., PMID:40071424
Highlights from the breakout session: optimising new treatments., PMID:40071420
Decreased concentrations of C5a complement receptor antibodies are associated with relapse in eosinophilic granulomatosis with polyangiitis (EGPA)., PMID:40050040
CD21lo B cell subsets are recruited to the central nervous system in acute neuromyelitis optica., PMID:40042820
Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis., PMID:40010959
Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders., PMID:39983521
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium., PMID:39969779
Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan., PMID:39844309
Autoantibodies cause nociceptive sensitization in a mouse model of degenerative osteoarthritis., PMID:39835597
Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy., PMID:39803605
AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia gravis., PMID:39676116
Expression of FcμR by bovine mononuclear blood leukocytes., PMID:39674305
Avacopan as an add-on therapy for ANCA-associated vasculitis: a pharmacological overview., PMID:39611585
Role of Avacopan on Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis., PMID:39597819
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial., PMID:39547392
An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19., PMID:39475087
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy., PMID:39458595
Serine protease RAYM_01812 (SspA) inhibits complement-mediated killing and monocyte chemotaxis and contributes to virulence of Riemerella anatipestifer in ducks., PMID:39450484
Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections., PMID:39383256
Functional dependence following intensive care unit-treated sepsis: three-year follow-up results from the prospective Mid-German Sepsis Cohort (MSC)., PMID:39308983
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)., PMID:39197587
Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD., PMID:39133885
Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis., PMID:39125933
Expression of the receptor for IgM (FcμR) by bovine neutrophils., PMID:39089639
Update on targeted treatments for ANCA-associated vasculitis., PMID:39089473
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series., PMID:39072008
Structure of Designer Antibody-like Peptides Binding to the Human C5a with Potential to Modulate the C5a Receptor Signaling., PMID:39051153
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults., PMID:39033312
Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicentre real-world study., PMID:39001799
Effect of Mild or Moderate Hepatic Impairment on the Pharmacokinetics of Avacopan, a Small-Molecule Complement C5a Receptor Antagonist, for the Treatment of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis., PMID:38993026
Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial., PMID:38943192
Elevated Complement Activation Fragments and C1q-Binding Circulating Immune Complexes in Varied Phases of Chikungunya Virus Infection., PMID:38913141
Serological Responses to Streptococcus pyogenes Vaccine Candidate Antigens Suggests That Streptococcus dysgalactiae Is the Predominant Cause of Lower Limb Cellulitis., PMID:38872850
FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα-CPT1a pathway., PMID:38837706
Crovalimab: First Approval., PMID:38740735
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome., PMID:38709420
Complement system is overactivated in patients with IgA nephropathy after COVID-19., PMID:38701960
Intravenous Ig Ameliorates Disease in a Murine Model of Anti-Laminin 332 Mucous Membrane Pemphigoid., PMID:38692406
A link between circulating immune complexes and acute kidney injury in human visceral leishmaniasis., PMID:38684845
For research use only. Not for human or drug use.
